RE:RE:RE:FDESLOGES , FRANÇCOIS 21.Alex1726,
Here what I've said earlier :
And both of us still having our shares,,,,,,
This is a so call article by a shorter spreading false informations and rumors.
First saying that PLI give half of the economic of the plasminogen is simply false, it's only applied to PD1. Any other application (would healing or any off label indication is not in the Hematech deal)
Also saying that competitors past over that protein is simply funny. The competitors didn't past over, they can't extract on a commerical scale.....
And saying that other fractionators extract the plasminogen as an impurity is totally absurb....
That lead to the second major lie, denying that the PPPS platform is more effective. On what base he said so:
The core technology was acquired for less than $5M.
Maybe he should consider the number of years and R&D dollars spent to bring it to the actual level.
And it's already proven effective and bring to commercial scale up.....
This is plain and stupid demagogy, not more, not less.
Another example of the plain and stupid demagogy is the talking about a graveyard of failing pipeline.
Well, if it's true that PLI did mentionned many coumpounds in the past, they were mentionned as discovery in pre clinical stage.
They are not yet push further in development simply for economic reason. This is not a failure.
PBI-1402 died simply because the FDA change the rules of approval for EPO alike molecules.
Saying that PBI-4050 will failed, is based simply on nothing.......
We can talk about the past, wich is nearly what seems to be true in this report, as for the missing target in revenues and missing promises. PLI is not perfect in everything.
However, starting talking about Crystal research for a report made in 2005, trying to make a case about pumped stuff is truly funny. We are in 2016, 11 years later.
Maybe instead of talking about what happened 11 years ago, he should talk a little more about the next 12 months....
For the rest, trying to make a point by attacking the Hybridan-PLI relation, is simply showing how poor is his analysis.
But Seeking Alpha blogs are not at their first false report, Nobilis Healthcare have been also targeted by shorter that made plenty of false claims while they short the stock.
I wonder about the legality of such article....
Read more at https://www.stockhouse.com/companies/bullboard/t.pli/prometic-life-sciences-inc?postid=25609218#oULLB4TAK8OHSkqt.99